NCT00638391已完成不适用
Postmenopausal Women With Early Hormone-Receptor Positive Breast Cancer/no Metastasis
适应症
干预措施
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- AstraZeneca
- 入组人数
- 1,600
- 主要终点
- evaluation of Anastrozole therapy as adjuvant treatment in post.menopausal women with not advanced breast cancer únder naturalistic conditions
研究概览
简要总结
The purpose of this study is the initial/followed by 5 year adjuvant therapy with Anastrozole.
研究设计
- 研究类型
- Observational
- 观察模型
- Case Only
- 时间视角
- Prospective
入排标准
- 性别
- Female
- 接受健康志愿者
- 否
入选标准
- •Postmenopausal women with early hormone receptor positive breast cancer/no metastasis
排除标准
- 未提供
研究组 & 干预措施
1
all patients treated with Anastrozole
干预措施: Anastrozole (Drug)
结局指标
主要结局
evaluation of Anastrozole therapy as adjuvant treatment in post.menopausal women with not advanced breast cancer únder naturalistic conditions
时间窗: 12 months
次要结局
- description of population treated with anastrozole(12 months)
- further information about the change of specific laboratory parameters(12 months)
研究者
相似试验
已完成
不适用
Neoadjuvant Hormonal Treatment of Postmenopausal Women Who Have Operable Breast CancerBreast CancerNCT00437853Instituto Nacional de Cancerologia de Mexico30
已完成
3 期
Comparison Trial of Letrozole to Anastrozole in the Adjuvant Treatment of Postmenopausal Women With Hormone Receptor and Node Positive Breast CancerBreast CancerNCT00248170Novartis Pharmaceuticals4,172
已完成
2 期
Optimal Duration of Pre-operative Treatment With Letrozole and to Correlate Clinical Efficacy With Appropriate Surrogate MarkersBreast CancerNCT00535418Novartis Pharmaceuticals35
尚未招募
不适用
Wat zijn de effecten van het middel Duogestan® op de kwaliteit van leven?NL-OMON22707Besins Healthcare100
Unknown
不适用
Effects of Adjuvant Endocrine Therapy With Aromatase Inhibitors on the Postoperative Lipid Levels in Postmenopausal Breast Cancer PatientsBreast CancerNCT02765373Chinese Academy of Medical Sciences500